SOST and chronic kidney disease: In CKD, circulating sclerostin levels are elevated and may function as a compensatory mechanism against ectopic calcification; thus, neutralization of sclerostin may lead to excessive Wnt pathway activation, disrupting bone-mineral homeostasis and predisposing patients to abnormal calcification.